Immunovant (IMVT) EPS (Basic) (2018 - 2026)
Immunovant (IMVT) posted EPS (Basic) of -$0.81 for Q1 2026, down 32.96% on a QoQ basis from -$0.61 in Q4 2025, and down 15.4% year-over-year from -$0.96 in Q1 2025.
Immunovant (IMVT) EPS (Basic) (2018 - 2026) Analysis & Trends
Immunovant's EPS (Basic) history runs 9 years deep, the most recent figure standing at -$0.81 for Q1 2026.
- Quarterly EPS (Basic) fell 15.4% year-over-year to -$0.81 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.77 (down 1.51% YoY) and the FY2026 annual result came in at -$2.77, down 1.51% from the prior year.
- EPS (Basic) was -$0.81 for Q1 2026 at Immunovant, down from -$0.61 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.35 in Q2 2022 and bottomed at -$0.81 in Q1 2026.
- A 5-year average of -$0.57 and a median of -$0.57 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) increased 27.65% — and 2024, when it slumped 112.59%.
- Immunovant's EPS (Basic) stood at -$0.49 in 2022, then advanced by 27.65% to -$0.36 in 2023, then plunged by 112.59% to -$0.76 in 2024, then rose by 19.41% to -$0.61 in 2025, then slumped by 32.96% to -$0.81 in 2026.
- Business Quant data shows IMVT's EPS (Basic) at -$0.81 in Q1 2026, -$0.61 in Q4 2025, and -$0.73 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Immunovant | 7.17 Bn | 7.17 Bn | - | -0.81 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.81 |
| Dec 31, 2025 | -0.61 |
| Sep 30, 2025 | -0.73 |
| Jun 30, 2025 | -0.71 |
| Mar 31, 2025 | -0.70 |
| Dec 31, 2024 | -0.76 |
| Sep 30, 2024 | -0.74 |
| Jun 30, 2024 | -0.60 |
| Mar 31, 2024 | -0.55 |
| Dec 31, 2023 | -0.36 |
| Sep 30, 2023 | -0.45 |
| Jun 30, 2023 | -0.57 |
| Mar 31, 2023 | -0.48 |
| Dec 31, 2022 | -0.49 |
| Sep 30, 2022 | -0.41 |
| Jun 30, 2022 | -0.35 |
| Mar 31, 2022 | -0.43 |
| Dec 31, 2021 | -0.36 |
| Sep 30, 2021 | -0.35 |
| Jun 30, 2021 | -0.31 |